Chembio Diagnostics Inc  

(Public, NASDAQ:CEMI)   Watch this stock  
Find more results for CEMI
4.10
-0.03 (-0.73%)
Real-time:   11:07AM EST
NASDAQ real-time data - Disclaimer
Currency in USD
Range 4.09 - 4.13
52 week 2.83 - 5.20
Open 4.13
Vol / Avg. 8,050.00/27,326.00
Mkt cap 39.50M
P/E     -
Div/yield     -
EPS -0.10
Shares 9.61M
Beta 0.15
Inst. own 20%
Mar 5, 2015
Q4 2014 Chembio Diagnostics Inc Earnings Call
Mar 5, 2015
Q4 2014 Chembio Diagnostics Inc Earnings Release
Jan 13, 2015
Chembio Diagnostics Inc at EBD Biotech Showcase
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin -3.70% 1.80%
Operating margin -3.59% 3.40%
EBITD margin - 5.46%
Return on average assets -4.52% 2.54%
Return on average equity -5.38% 3.12%
Employees 206 -
CDP Score - -

Address

3661 Horseblock Road
MEDFORD, NY 11763
United States - Map
+1-631-9241135 (Phone)
+1-775-8849383 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Chembio Diagnostics, Inc. develops, manufactures, markets and licenses rapid point-of-care diagnostic tests (POCTs) that detect infectious diseases. The Company's main products available are four rapid tests for the detection of HIV 1/2 antibodies, two rapid tests for the detection of syphilis antibodies, and a multiplex rapid test for the detection of HIV and Syphilis antibodies. Three of the HIV 1/2 rapid tests employ in-licensed and lateral flow technologies, can be used with all blood matrices as samples, and are manufactured in a standard cassette format, a dipstick format, and a barrel format. The Company�s fourth HIV 1/2 rapid antibody detection test incorporates its Dual Path Platform (DPP) POCT technology.

Officers and directors

John J. Sperzel III President, Chief Executive Officer, Director
Age: 50
Bio & Compensation  - Reuters
Richard J. Larkin Chief Financial Officer
Age: 57
Bio & Compensation  - Reuters
Sharon Klugewicz Chief Operating Officer
Age: 46
Bio & Compensation  - Reuters
Javan Esfandiari Sr. VP - Research and Development
Age: 47
Bio & Compensation  - Reuters
Tom Ippolito Vice President - Regulatory Affairs, Quality Assurance and Quality Control
Age: 50
Bio & Compensation  - Reuters
Paul Lambotte Ph.D. Vice President - Product Development
Bio & Compensation  - Reuters
Katherine L. Davis Non-Executive Independent Chairman of the Board
Age: 57
Bio & Compensation  - Reuters
Barbara A. DeBuono M.D., M.P.H. Independent Director
Age: 59
Bio & Compensation  - Reuters
Peter T. Kissinger Ph.D. Independent Director
Age: 69
Bio & Compensation  - Reuters
Gary Meller M.D. Independent Director
Age: 64
Bio & Compensation  - Reuters